GHCM
ASMB icon

Glen Harbor Capital Management’s Assembly Biosciences ASMB Stock Holding History

Glen Harbor Capital Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-40
Closed -$9K – 1325
2019
Q1 		$9K Sell
40
-37
-48% -$9.37K ﹤0.01% 1294
2018
Q4 		$21K Buy
+77
New +$22.3K ﹤0.01% 1229

Other funds holding ASMB

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Glen Harbor Capital Management's ASMB Position: Q2 2019 in Review

Glen Harbor Capital Management sold out of Assembly Biosciences (ASMB) in Q2 2019, closing a stake of 40 shares — an estimated $9K sold.

Glen Harbor Capital Management first reported a position in ASMB in Q4 2018 and held it in 2 quarters. The position peaked at $21K in Q4 2018. 106 funds tracked by Wall St. Rank hold ASMB as of Q2 2019.

  • Glen Harbor Capital Management reported no remaining Assembly Biosciences position as of Q2 2019 after selling out during the quarter.
  • Glen Harbor Capital Management sold 40 Assembly Biosciences shares in Q2 2019, an estimated $9K.
  • Glen Harbor Capital Management first reported a position in Assembly Biosciences in Q4 2018 and held it in 2 quarters.
  • Glen Harbor Capital Management's Assembly Biosciences position peaked at $21K in Q4 2018.
  • 106 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2019.

Based on Glen Harbor Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.